Riham Bokhtia | Molecular | Editorial Board Member

Published on by Research Chemistry Awards

Editorial Board Member

  Riham Bokhtia
Affiliation Faculty of Pharmacy, Zagazig University
Country Egypt
Scopus ID 57209660751
Documents 13
Citations 152
h-index 6
Subject Area Molecular
Event International Research Chemistry Awards
ORCID 0000-0001-5326-7364

Riham Bokhtia is affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, and has developed a research profile represented in international scholarly indexing systems. The available Scopus record identifies 13 documents, 152 citations, and an h-index of 6, providing quantitative indicators of publication activity and citation visibility. [1]

Abstract

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy, Zagazig University, Egypt. Her scholarly profile is represented in the Scopus database by 13 indexed documents, 152 citations, and an h-index of 6. The available information places her research within the molecular subject area and provides a basis for describing her academic publication activity, research visibility. [1]

Keywords

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, with research interests spanning molecular chemistry. Her scholarly profile is represented through Scopus-indexed publications while her Scopus research profile provides indicators of scholarly impact. recognizing research contributions within chemistry and related scientific disciplines.[2]

Introduction

Academic research profiles provide a structured means of evaluating scholarly activity through publication records, citation patterns, and bibliometric indicators. Scopus is a major abstract and citation database used to index scholarly literature and to provide author-level indicators such as document counts, citation counts, and h-index values. [1]

Research Profile

The available bibliometric information identifies a documented research record associated with a Scopus Author profile. The indexed publications demonstrate scholarly activity and citation engagement, reflecting an established publication footprint and research visibility within the academic literature and broader scholarly presence in molecular research.[4]

Research Contributions

Bokhtia’s research profile is situated at the intersection of molecular science and pharmaceutical research. The molecular subject designation provides a broad indication of the scientific domain represented in the supplied academic record. Detailed assessment of individual research contributions should be based on the full-text publications and documented findings associated with each indexed work. [3]

Publications

For formal academic evaluation, the publication record can be reviewed through the researcher’s Scopus profile and, where available, individual publisher records and DOI registrations. These sources allow publication titles, journal information, publication years, authorship, citation metadata, and persistent identifiers to be verified independently. [4]

Research Impact

The reported 152 citations provide an observable indicator of scholarly use or discussion of the indexed documents, while the h-index of 6 indicates that at least six indexed publications have each received at least s ix citations under the relevant database calculation. Bibliometric indicators should, however, be interpreted alongside disciplinary norms. [2]

Award Suitability

On the supplied evidence, her profile demonstrates established scholarly activity through 13 Scopus-indexed documents, 152 citations, and an h-index of 6.  Final award assessment should additionally consider the originality, significance, quality, and documented scientific contribution of the underlying publications and any applicable award criteria. [3]

Conclusion

Riham Bokhtia’s academic profile reflects a documented research presence in the molecular and pharmaceutical research context. Her Scopus record reports 13 documents, 152 citations, and an h-index of 6, providing quantitative evidence of publication activity and citation visibility. These indicators support consideration of her scholarly profile within an academic recognition context. [4]

References

  1. Elsevier. (n.d.). Scopus author details: Riham Bokhtia, Author ID 57209660751. Scopus.
    https://www.scopus.com/pages/authors/57209660751
  2. ORCID. (n.d.). ORCID record for Riham Bokhtia.
    https://orcid.org/0000-0001-5326-7364
  3. International Research Chemistry Awards. (n.d.).
    https://researchchemistry.org
  4. Bokhtia, R. M., et al. (n.d.). Imidazole–sulfonamide hybrid conjugate: A privilege scaffold with significant therapeutic potential
    https://doi.org/10.1016/j.ejmcr.2025.100321

Prof. John Carethers | Proteomics | Best Researcher Award

Published on by Research Chemistry Awards

Prof. John Carethers | Proteomics | Best Researcher Award

Dr. John M. Carethers is an esteemed physician-scientist and healthcare leader currently serving as Vice Chancellor for Health Sciences at the University of California San Diego. He is also a Distinguished Professor of Medicine and an Adjunct Professor in Public Health. With a strong clinical and academic background in gastroenterology and internal medicine, Dr. Carethers is widely recognized for his research in colorectal cancer, tumor genetics, and health disparities. He has held numerous leadership roles and contributed significantly to national medical organizations. His dedication to mentoring, research, and equitable healthcare continues to shape the future of medical science and education.

UC San Diego | United States

Author Profile

Google Scholar

Education and Training

Dr. John M. Carethers began his academic journey at Wayne State University, Detroit, Michigan, where he earned a B.S. in Biological Sciences with a minor in Chemistry (1981–1985). He continued at Wayne State University School of Medicine, graduating with High Distinction with an M.D. in 1989. He then completed an Internship (1989–1990) and Residency (1990–1992) in Internal Medicine at Massachusetts General Hospital in Boston under the leadership of Dr. John T. Potts. Dr. Carethers pursued a Fellowship in Gastroenterology at the University of Michigan Medical Center from 1992 to 1995 and simultaneously engaged in postdoctoral research training under Dr. Stephen J. Weiss. From 1993 to 1995, he worked as a research-track fellow in the laboratory of Dr. C. Richard Boland, focusing on the genetics and mechanisms of cell death in colon cancer. He further expanded his leadership skills through several executive programs, including the AAIM Executive Leadership Program at Harvard (2005), UCSD Physician Leadership Academy (2007–2009), AAMC Council of Deans Fellowship (2015–2016), and the Big Ten Academic Alliance Leadership Program (2018–2019).

Research Interests

Dr. Carethers is internationally recognized for his work in colorectal cancer research. His areas of expertise include mechanisms of tumor progression, tumor genetics, and tumor markers. He has conducted extensive studies on DNA mismatch repair, molecular pathology, and microsatellite instability. His work also addresses familial cancer syndromes, disparities in colorectal cancer outcomes among minority populations, and strategies to improve colorectal cancer screening—especially in early-onset cases.

Honors and Awards

Dr. Carethers has received numerous prestigious awards and honors throughout his career. Notably, in 2023, he was the Commencement Keynote Speaker at Stonybrook University Renaissance School of Medicine and was honored with the naming of the “John Carethers, MD Conference Room” at the University of Michigan. He was elected Vice-President of the American Clinical and Climatological Association (ACCA) and became a member of the Blue Ridge Academic Health Group (BRAHG). In 2024, he was inducted as a Fellow of the American Association for Cancer Research (FAACR) and received the Recognition Award at the 10th Annual Cancer Health Disparities Symposium hosted by SUNY Downstate Health Sciences University.

Memberships and Professional Activities

Dr. Carethers is deeply involved in academic leadership and professional mentoring. He has served as a mentor for Research Scholar Awardees from the University of Kansas and Duke University. He was part of the AGA’s DDW Abstract Review panel (2023), chaired the AGA Recognition Prize Selection Committee (2023–2024), and served on the AGA Leadership Pathways Task Force (2024–2025). His commitment to addressing social determinants of health was evident as he spoke at the DDW session on Food Insecurity and Colon Cancer in Washington, D.C., in May 2024. Additionally, he is a reviewer for the GI Opportunity Fund and continues to engage in collaborative efforts to enhance colorectal cancer screening strategies, including with Exact Sciences.

Notable Publications

Genomic and epigenetic instability in colorectal cancer pathogenesis
Authors: William M Grady, John M Carethers
Journal: Gastroenterology
Year: 2008

Genetics and genetic biomarkers in sporadic colorectal cancer
Authors: John M Carethers, Barbara H Jung
Journal: Gastroenterology
Year: 2015

Mismatch repair proficiency and in vitro response to 5-fluorouracil
Authors: John M Carethers, Dharam P Chauhan, Daniel Fink, Sibylle Nebel, Robert S Bresalier, Stephen B Howell, C Richard Boland
Journal: Gastroenterology
Year: 1999

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
Authors: John M Carethers, E Julieta Smith, Cynthia A Behling, Lanchinh Nguyen, Akihiro Tajima, Ryan T Doctolero, Betty L Cabrera, Ajay Goel, Christian A Arnold, Katsumi Miyai, C Richard Boland
Journal: Gastroenterology
Year: 2004

Evidence for a Connection between the Mismatch Repair System and the G2 Cell Cycle Checkpoint
Authors: Mary T Hawn, Asad Umar, John M Carethers, Giancarlo Marra, Thomas A Kunkel, C Richard Boland, Minoru Koi
Journal: Cancer Research
Year: 1995